Failure of the aldosterone antagonist spironolactone to inhibit myocardial hypertrophy produced by experimental hyperthyroidism and accompanied by "apparent" digoxin immunoreactivity in the blood.
D000818:Animals; D000937:Antigen-Antibody Reactions; D006332:Cardiomegaly / Q000209:etiology* / Q000276:immunology / Q000517:prevention & control; D004077:Digoxin / Q000276:immunology*; D006321:Heart / Q000187:drug effects; D006980:Hyperthyroidism / Q000150:complications*; D008297:Male; D009929:Organ Size / Q000187:drug effects; D051381:Rats; D013148:Spironolactone / Q000494:pharmacology*; D013974:Thyroxine / Q000494:pharmacology
D013148:Spironolactone; D004077:Digoxin; D013974:Thyroxine